Nuvation Bio (Nuvation Bio) Price-to-Tangible-Book : 1.54 (As of Apr. 27, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Nuvation Bio Price-to-Tangible-Book?

As of today (2024-04-27), Nuvation Bio's share price is $5.435. Nuvation Bio's Tangible Book per Share of Sep. 2021 for the quarter that ended in Sep. 2021 was $3.53. Hence, Nuvation Bio's Price to Tangible Book Ratio of today is 1.54.

The historical rank and industry rank for Nuvation Bio's Price-to-Tangible-Book or its related term are showing as below:

NUVB' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.43 Med: 2.19 Max: 2.81
Current: 1.59

During the past 2 years, Nuvation Bio's highest Price to Tangible Book Ratio was 2.81. The lowest was 1.43. And the median was 2.19.

NUVB's Price-to-Tangible-Book is not ranked
in the Biotechnology industry.
Industry Median: 2.65 vs NUVB: 1.59

A closely related ratio is called PB Ratio. As of today, Nuvation Bio's share price is $5.435. Nuvation Bio's Book Value per Sharefor the quarter that ended in Sep. 2021 was $3.53. Hence, Nuvation Bio's P/B Ratio of today is 1.54.

Nuvation Bio Price-to-Tangible-Book Historical Data

The historical data trend for Nuvation Bio's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuvation Bio Price-to-Tangible-Book Chart

Nuvation Bio Annual Data

Trend

Dec20

Dec21

Price-to-Tangible-Book

1.81

Nuvation Bio Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21
Price-to-Tangible-Book	Get a 7-Day Free Trial			1.81	-	2.57	2.81	-

Competitive Comparison of Nuvation Bio's Price-to-Tangible-Book

For the Biotechnology subindustry, Nuvation Bio's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nuvation Bio's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nuvation Bio's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Nuvation Bio's Price-to-Tangible-Book falls into.

Nuvation Bio Price-to-Tangible-Book Calculation

Nuvation Bio's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Sep. 2021 )
	=	5.435	/	3.533
	=	1.54

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Nuvation Bio Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Nuvation Bio's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Nuvation Bio (Nuvation Bio) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

1500 Broadway, Suite 1401, New York, NY, USA, 10036

Website

https://www.nuvationbio.com

Nuvation Bio Inc is a biopharmaceutical company. The company is engaged in developing therapeutic candidates for the unmet needs in oncology. The firm operates in pharmaceutical, biotechnology and other related markets that develop small molecules and drug conjugates as treatments for cancer patients.